Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.

<h4>Background</h4>Chemotherapy is essential to improve the prognosis of the patients with osteosarcoma, and the response to chemotherapy is an important prognostic factor. In this study, the impact of various radiological examinations on overall survival (OS) and event-free survival (EF...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shinji Miwa, Akihiko Takeuchi, Toshiharu Shirai, Junichi Taki, Norio Yamamoto, Hideji Nishida, Katsuhiro Hayashi, Yoshikazu Tanzawa, Hiroaki Kimura, Kentaro Igarashi, Akishi Ooi, Hiroyuki Tsuchiya
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/348e6e348ffd4ee9a8f6020f34cc2df9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:348e6e348ffd4ee9a8f6020f34cc2df9
record_format dspace
spelling oai:doaj.org-article:348e6e348ffd4ee9a8f6020f34cc2df92021-11-18T09:02:20ZPrognostic value of radiological response to chemotherapy in patients with osteosarcoma.1932-620310.1371/journal.pone.0070015https://doaj.org/article/348e6e348ffd4ee9a8f6020f34cc2df92013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23922892/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Chemotherapy is essential to improve the prognosis of the patients with osteosarcoma, and the response to chemotherapy is an important prognostic factor. In this study, the impact of various radiological examinations on overall survival (OS) and event-free survival (EFS) was evaluated.<h4>Method</h4>Eighty-two patients with high-grade osteosarcoma were included in this study, and we evaluated the following factors for prognostic significance: age (≥40 years), gender (male), tumor location (truncal site), metastatic disease, histological response to chemotherapy, radiological response to chemotherapy assessed using X-ray, angiography, CT, MRI, (201)Tl scintigraphy, and (99m)Tc-MIBI scintigraphy ((99m)Tc-MIBI), and combined radiological score (CRS).<h4>Results</h4>Univariate analyses revealed that metastatic disease, histological response, (99m)Tc-MIBI, and CRS were significantly correlated with OS. Multivariate analyses showed that metastatic disease (OS: HR 35.9, P<0.001; EFS: HR 17.32, P<0.001) was an independent predictor of OS and EFS. Tumor location (HR 36.1, P = 0.003), histological response (HR 31.1, P = 0.036), and (99m)Tc-MIBI (HR 18.4, P = 0.038) were significant prognostic factors for OS. Moreover, CRS was a marginally significant predictor of OS and EFS.<h4>Conclusion</h4>The chemotherapeutic effects evaluated by (99m)Tc-MIBI and CRS could be considered as prognostic factors in osteosarcoma.Shinji MiwaAkihiko TakeuchiToshiharu ShiraiJunichi TakiNorio YamamotoHideji NishidaKatsuhiro HayashiYoshikazu TanzawaHiroaki KimuraKentaro IgarashiAkishi OoiHiroyuki TsuchiyaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e70015 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shinji Miwa
Akihiko Takeuchi
Toshiharu Shirai
Junichi Taki
Norio Yamamoto
Hideji Nishida
Katsuhiro Hayashi
Yoshikazu Tanzawa
Hiroaki Kimura
Kentaro Igarashi
Akishi Ooi
Hiroyuki Tsuchiya
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
description <h4>Background</h4>Chemotherapy is essential to improve the prognosis of the patients with osteosarcoma, and the response to chemotherapy is an important prognostic factor. In this study, the impact of various radiological examinations on overall survival (OS) and event-free survival (EFS) was evaluated.<h4>Method</h4>Eighty-two patients with high-grade osteosarcoma were included in this study, and we evaluated the following factors for prognostic significance: age (≥40 years), gender (male), tumor location (truncal site), metastatic disease, histological response to chemotherapy, radiological response to chemotherapy assessed using X-ray, angiography, CT, MRI, (201)Tl scintigraphy, and (99m)Tc-MIBI scintigraphy ((99m)Tc-MIBI), and combined radiological score (CRS).<h4>Results</h4>Univariate analyses revealed that metastatic disease, histological response, (99m)Tc-MIBI, and CRS were significantly correlated with OS. Multivariate analyses showed that metastatic disease (OS: HR 35.9, P<0.001; EFS: HR 17.32, P<0.001) was an independent predictor of OS and EFS. Tumor location (HR 36.1, P = 0.003), histological response (HR 31.1, P = 0.036), and (99m)Tc-MIBI (HR 18.4, P = 0.038) were significant prognostic factors for OS. Moreover, CRS was a marginally significant predictor of OS and EFS.<h4>Conclusion</h4>The chemotherapeutic effects evaluated by (99m)Tc-MIBI and CRS could be considered as prognostic factors in osteosarcoma.
format article
author Shinji Miwa
Akihiko Takeuchi
Toshiharu Shirai
Junichi Taki
Norio Yamamoto
Hideji Nishida
Katsuhiro Hayashi
Yoshikazu Tanzawa
Hiroaki Kimura
Kentaro Igarashi
Akishi Ooi
Hiroyuki Tsuchiya
author_facet Shinji Miwa
Akihiko Takeuchi
Toshiharu Shirai
Junichi Taki
Norio Yamamoto
Hideji Nishida
Katsuhiro Hayashi
Yoshikazu Tanzawa
Hiroaki Kimura
Kentaro Igarashi
Akishi Ooi
Hiroyuki Tsuchiya
author_sort Shinji Miwa
title Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
title_short Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
title_full Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
title_fullStr Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
title_full_unstemmed Prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
title_sort prognostic value of radiological response to chemotherapy in patients with osteosarcoma.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/348e6e348ffd4ee9a8f6020f34cc2df9
work_keys_str_mv AT shinjimiwa prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT akihikotakeuchi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT toshiharushirai prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT junichitaki prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT norioyamamoto prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT hidejinishida prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT katsuhirohayashi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT yoshikazutanzawa prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT hiroakikimura prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT kentaroigarashi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT akishiooi prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
AT hiroyukitsuchiya prognosticvalueofradiologicalresponsetochemotherapyinpatientswithosteosarcoma
_version_ 1718421014923182080